News
Researchers Find Potential for Repurposing Drug to Target Certain Types of Leukemia Cells
05/19/2022
Drs. Jha and Maciejewski have identified eltrombopag as a potent inhibitor of specific leukemia cells, which could lead to new drugs that target leukemia cells while preserving and expanding normal blood cells.
Read More
Flipping the Switch on Prostate Cancer Immunotherapy
05/18/2022
Dr. Nima Sharifi and a team of researchers uncovered how tumors circumvent prostate cancer therapy and identified a potential window of time after treatment when tumors may be responsive to immunotherapy.
Read More
Exploring a Blood-Based Biomarker of Inflammation for Alzheimer’s Disease
05/16/2022
Dr. Bekris’ team found that patterns of sTREM2-related inflammatory activity were specific to Alzheimer’s disease stages.
Read MoreNew Global Center for Pathogen and Human Health Research
The Global Center for Pathogen and Human Health Research will bring together a research team to broaden understanding of viral pathogens and the human immune response toward preparing and protecting against future public health threats.
LEARN MORE
Accelerating Discoveries to Patients
Working together with Cleveland Clinic physicians, our scientists are discovering the treatments of tomorrow. While many spend their days working at the laboratory bench, their inspiration can be found at the patient bedside.
Education & Training
Postdoctoral Program
Train on the cutting-edge of research and join our thriving postdoc association.
Learn MoreMolecular Medicine PhD Program
Earn your PhD through our unique program that combines basic science and medical knowledge.
Learn More